Browsing byAuthorYenson, VM
Showing results 1 to 6 of 6
| Issue Date | Title | Author(s) |
| 2017-09-04 | Blimp-1-dependent and -independent natural antibody production by B-1 and B-1-derived plasma cells. | Savage, HP; Yenson, VM; Sawhney, SS; Mousseau, BJ; Lund, FE; Baumgarth, N |
| 2023-07-03 | Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study. | Yenson, VM; Amgarth-Duff, I; Brown, L; Caperchione, CM; Clark, K; Cross, A; Good, P; Landers, A; Luckett, T; Philip, J; Steer, C; Vardy, JL; Wong, AK; Agar, MR |
| 2016-10-21 | Embryonic/fetal mortality and intrauterine growth restriction is not exclusive to the CBA/J sub-strain in the CBA × DBA model. | McKelvey, KJ; Yenson, VM; Ashton, AW; Morris, JM; McCracken, SA |
| 2016-04-18 | NF-κB Regulation in T-cells in Pregnancy is Mediated via Fas/FasL Interactions: The Signal for which is Derived from Exosomes Present in Maternal Plasma | McCracken, S; Hadfield, KA; Yenson, VM; Ariyakumar, G; McKelvey, KJ; Woodland, NB; Ashton, AW; Morris, JM |
| 2024-06-03 | Patient-reported use of pancreatic enzyme replacement treatment (PERT) in pancreatic cancer in New Zealand and Australia: a cross-sectional survey study. | Landers, A; Brown, H; Al Ruheili, J; Russell, K; McKenzie, C; Agar, MR; Yenson, VM; Clarke, K; Windsor, J |
| 2024-10-13 | Prescribing of pancreatic enzyme therapy for malabsorption in unresectable pancreatic cancer: Cross-sectional survey across New Zealand and Australia. | Landers, A; Brown, H; Russell, K; Fanning, N; Fu, F; McKenzie, C; Agar, MR; Yenson, VM; Clarke, K; Windsor, J |
